Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Shinkai

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Nihon Sanka Fujinka Gakkai Zasshi|May 1, 1987
[MTX resistant mechanisms in human choriocarcinoma cells]K Sakai, T Fujino, S Hoshi, et al.
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|July 1, 1986
[Establishment and characterization of the cell line derived from low differentiated adenocarcinoma of the endometrium]N Shinkai, H Fujita, K Sakai, et al.
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|January 1, 1984
[The age incidence of spontaneous abortion]Y Shiina, K Okuyama, W Takeda, et al.
The Japanese Journal of Antibiotics|June 1, 1986
[Clinical evaluation of imipenem/cilastatin sodium in gynecological infection]M Iwaki, H Sato, S Makinoda, et al.
Gynecologic Oncology|May 2, 2001
Genetic origin of malignant trophoblastic neoplasms analyzed by sequence tag site polymorphic markersN Shahib, D Martaadisoebrata, H Kondo, et al.
Journal of Viral Hepatitis|March 16, 2013
Mechanism of the dependence of hepatitis B virus genotype G on co-infection with other genotypes for viral replicationT Sakamoto, Y Tanaka, T Watanabe, et al.
Journal of Viral Hepatitis|April 23, 2014
ITPA genetic variants influence efficacy of PEG-IFN/RBV therapy in older patients infected with HCV genotype 1 and favourable IL28B typeK Matsuura, Y Tanaka, T Watanabe, et al.
Gut|May 8, 2007
Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levelsM-F Yuen, Y Tanaka, N Shinkai, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Nihon Sanka Fujinka Gakkai Zasshi|May 1, 1987
[MTX resistant mechanisms in human choriocarcinoma cells]K Sakai, T Fujino, S Hoshi, et al.
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|July 1, 1986
[Establishment and characterization of the cell line derived from low differentiated adenocarcinoma of the endometrium]N Shinkai, H Fujita, K Sakai, et al.
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|January 1, 1984
[The age incidence of spontaneous abortion]Y Shiina, K Okuyama, W Takeda, et al.
The Japanese Journal of Antibiotics|June 1, 1986
[Clinical evaluation of imipenem/cilastatin sodium in gynecological infection]M Iwaki, H Sato, S Makinoda, et al.
Gynecologic Oncology|May 2, 2001
Genetic origin of malignant trophoblastic neoplasms analyzed by sequence tag site polymorphic markersN Shahib, D Martaadisoebrata, H Kondo, et al.
Journal of Viral Hepatitis|March 16, 2013
Mechanism of the dependence of hepatitis B virus genotype G on co-infection with other genotypes for viral replicationT Sakamoto, Y Tanaka, T Watanabe, et al.
Journal of Viral Hepatitis|April 23, 2014
ITPA genetic variants influence efficacy of PEG-IFN/RBV therapy in older patients infected with HCV genotype 1 and favourable IL28B typeK Matsuura, Y Tanaka, T Watanabe, et al.
Gut|May 8, 2007
Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levelsM-F Yuen, Y Tanaka, N Shinkai, et al.
Pageof 3